Physical Activity Intervention With People at Increased Risk of Developing Colon Cancer
PARC
A Randomised Controlled Trial Investigating the Effect of a 12 Month Active Lifestyle Programme on Physiological Risk Markers and Physical Activity Behaviour in Those Diagnosed With Intermediate or High Risk for Colon Cancer
1 other identifier
interventional
31
0 countries
N/A
Brief Summary
The present study will use a randomised controlled trial design to investigate whether moderate to vigorous intensity physical activity (MVPA) will affect the physiological risk markers associated with the development of bowel cancer in individuals previously diagnosed with a bowel polyp. The study will also investigate the effects of the programme on long-term exercise behaviour and changes in psychological variables. A selected sample will also be part of individual interviews at baseline and 12 months to gauge narrative accounts of personal, psychological and sociological beliefs surrounding participation in physical activity. The findings of this study might inform better practices for the prevention of bowel cancer in high risk populations. After a screening colonoscopy, eligible participants will be randomised to either an active lifestyle programme (ALP) or a standard care group (SC). Participants in ALP will be offered supervised exercise sessions and motivational interviewing for 6 months. Intervention components will cease after 6 months, but participants will be followed-up at 12 months to investigate maintenance to physical activity over the long-term. The SC will not be offered the intervention until the end of the study. Participants in both groups will be invited for assessments at baseline, 3, 6, 9, and 12 months. These include measurements of body composition, cardiopulmonary fitness, physical activity behaviour, and psycho-social variables.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2011
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedFirst Submitted
Initial submission to the registry
February 12, 2016
CompletedFirst Posted
Study publicly available on registry
March 31, 2016
CompletedMarch 31, 2016
March 1, 2016
3.5 years
February 12, 2016
March 24, 2016
Conditions
Outcome Measures
Primary Outcomes (4)
Change in DNA methylation in genes associated with inflammation and colon carcinogenesis
0, 6, 12 months
Compliance to intervention
Physical activity diary used to assess compliance
post-intervention (at 6months)
Change in minutes spent in moderate and vigorous intensity physical activity measure with the International Physical Activity Questionnaire long version
0, 3, 6, 9,12
Change in minutes spent in moderate and vigorous intensity leisure activity assessed with the Godin Leisure-Time Exercise Questionnaire
0, 3, 6, 9, 12
Secondary Outcomes (9)
Change in behavioural regulation measure with the Behavioural Regulation in Exercise Questionnaire version 2
0, 3, 6, 9, 12 months
Change in Quality of life measure with the SF-36 questionnaire
0, 3, 6, 9, 12 months
Changes in anthropometric measures (height, weight, BMI)
0, 3, 6, 9, 12 months
Change in physical fitness
0, 6, 12 months
Change in intention to exercise
0, 3, 6, 9, 12 months
- +4 more secondary outcomes
Study Arms (2)
Active Lifestyle Programme
EXPERIMENTALALP will receive supervised exercise sessions twice per week for three months and once per week for the following three months. Participants will also take part in biweekly physical activity workshops for the period of the intervention. Each session consists of a warm-up (5-10min), aerobic (20-30min) and resistance exercises (15-20), and cool-down (5-10)stretches lasting in total 60min. The intensity of exercises will be at 65-85% of maximum heart rate as determined by maximal fitness test. Exercise will take place in small groups of two to five people. Behaviour change workshops to aid the uptake and maintenance of physical activity will be delivered every fortnight throughout the whole intervention period totalling 12 workshops. Workshops will also take place in small groups.
Standard Care
NO INTERVENTIONThe standard care group will not be offered the intervention until the end of the study at 12 months. Participants in this group will be encouraged to continue with their usual lifestyle.
Interventions
Eligibility Criteria
You may qualify if:
- diagnosis of 'intermediate' to 'high' risk as a result of the screening colonoscopy-
- aged 60 years and above
- physically able to partake in regular exercise
You may not qualify if:
- assignment into the 'low risk' category or diagnosis of colorectal cancer following the colonoscopy;
- physical activity levels of at least 150min per week for the last 6 months
- presence or history of other co-morbid conditions which might preclude patients from safely undertaking regular exercise, including cardiovascular or pulmonary disease or stroke
- presence of other colorectal conditions (e.g. inflammatory bowel disease) or known familial colorectal cancer syndrome
- chronic use of any treatments or alternative therapies that may affect the results of any study of colorectal tissue e.g. high corticosteroid, anticoagulant or laxative use, regular enemas, high dose vitamin or antioxidant supplements, etc.;
- previous diagnosis of cancer;
- inability to adequately understand written and spoken English,
- presence of drug controlled type II diabetes mellitus
- current involvement in other ongoing research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John M Saxton, PhD
University of Northumbria
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2016
First Posted
March 31, 2016
Study Start
March 1, 2011
Primary Completion
September 1, 2014
Study Completion
September 1, 2014
Last Updated
March 31, 2016
Record last verified: 2016-03
Data Sharing
- IPD Sharing
- Will not share